Mesirow Financial Investment Management, Inc. Opti Nose, Inc. Transaction History

Mesirow Financial Investment Management, Inc.

$4.94 Billion
Q3 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 13, 2020	SELL	$3.69 - $7.09 $123,799 - $237,869	-33,550 Closed	0 $0
Q2 2020 Jul 22, 2020	SELL	$3.58 - $7.44 $3,000 - $6,234	-838 Reduced 2.44%	33,550 $250,000
Q1 2020 Apr 09, 2020	SELL	$3.49 - $9.2 $1,263 - $3,330	-362 Reduced 1.04%	34,388 $154,000
Q4 2019 Jan 09, 2020	BUY	$6.27 - $11.41 $217,882 - $396,497	34,750 New	34,750 $320,000

Others Institutions Holding OPTN

# of Institutions

Shares Held

88.3M

Call Options Held

Put Options Held

Mvm Partners, LLC Boston, MA

14.6M
Shares

$7.45 Million
10.4% of portfolio
Nantahala Capital Management, LLC New Canaan, CT

14.4M
Shares

$7.32 Million
0.57% of portfolio
Great Point Partners LLC Greenwich, CT

12.9M
Shares

$6.56 Million
3.98% of portfolio
Stonepine Capital Management, LLC Bend, OR

5.69M
Shares

$2.9 Million
2.41% of portfolio
Kingdon Capital Management, L.L.C. New York, NY

5.6M
Shares

$2.86 Million
0.45% of portfolio

View Full List

About OptiNose, Inc.

Ticker OPTN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 83,277,504
Market Cap $42.5M
Description
OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...

More about OPTN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mesirow Financial Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mesirow Financial Investment Management, Inc. with notifications on news.

Account